It was not possible to maintain SET knockdown in our cells by CRISPR-Cas9, shRNA or siRNA: our results suggest that AML cell lines could be dependent on SET high expression levels for sustained oncogenic growth and that SET knockout could seriously affect their viability and limit the number of cells available for further experiments). The gene discussed is SET; the disease is acute myeloid leukemia.